BEV-IP: Perioperative Chemotherapy With Bevacizumab in Patients Undergoing Cytoreduction and Intraperitoneal Chemoperfusion for Colorectal Carcinomatosis
BMC Cancer - United Kingdom
doi 10.1186/s12885-015-1954-x
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2015
Authors
Publisher
Springer Science and Business Media LLC